133 related articles for article (PubMed ID: 34522028)
41. Distinct domains of antizyme required for binding and proteolysis of ornithine decarboxylase.
Li X; Coffino P
Mol Cell Biol; 1994 Jan; 14(1):87-92. PubMed ID: 8264655
[TBL] [Abstract][Full Text] [Related]
42. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
43. IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.
Hagemann S; Misiak D; Bell JL; Fuchs T; Lederer MI; Bley N; Hämmerle M; Ghazy E; Sippl W; Schulte JH; Hüttelmaier S
Mol Cancer; 2023 May; 22(1):88. PubMed ID: 37246217
[TBL] [Abstract][Full Text] [Related]
44. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
45. Systemic overexpression of antizyme 1 in mouse reduces ornithine decarboxylase activity without major changes in tissue polyamine homeostasis.
Pietilä M; Dhungana H; Uimari A; Sironen R; Alhonen L
Transgenic Res; 2014 Feb; 23(1):153-63. PubMed ID: 24174210
[TBL] [Abstract][Full Text] [Related]
46. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
47. Antizyme2 is a negative regulator of ornithine decarboxylase and polyamine transport.
Zhu C; Lang DW; Coffino P
J Biol Chem; 1999 Sep; 274(37):26425-30. PubMed ID: 10473601
[TBL] [Abstract][Full Text] [Related]
48. Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.
Ruiz-Pérez MV; Medina MÁ; Urdiales JL; Keinänen TA; Sánchez-Jiménez F
J Biol Chem; 2015 Mar; 290(10):6106-19. PubMed ID: 25593318
[TBL] [Abstract][Full Text] [Related]
49. Forced expression of antizyme abolishes ornithine decarboxylase activity, suppresses cellular levels of polyamines and inhibits cell growth.
Murakami Y; Matsufuji S; Miyazaki Y; Hayashi S
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):183-7. PubMed ID: 7998932
[TBL] [Abstract][Full Text] [Related]
50. Polyamine homoeostasis.
Persson L
Essays Biochem; 2009 Nov; 46():11-24. PubMed ID: 20095967
[TBL] [Abstract][Full Text] [Related]
51. Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.
Gamble LD; Hogarty MD; Liu X; Ziegler DS; Marshall G; Norris MD; Haber M
Front Oncol; 2012; 2():162. PubMed ID: 23181218
[TBL] [Abstract][Full Text] [Related]
52. Polyamines regulate both transcription and translation of the gene encoding ornithine decarboxylase antizyme in mouse.
Nilsson J; Koskiniemi S; Persson K; Grahn B; Holm I
Eur J Biochem; 1997 Dec; 250(2):223-31. PubMed ID: 9428668
[TBL] [Abstract][Full Text] [Related]
53. Differentiation of a mouse neuroblastoma variant cell line whose ornithine decarboxylase gene has been amplified.
Chen ZP; Chen KY
Biochim Biophys Acta; 1991 Dec; 1133(1):1-8. PubMed ID: 1661161
[TBL] [Abstract][Full Text] [Related]
54. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme.
Palanimurugan R; Scheel H; Hofmann K; Dohmen RJ
EMBO J; 2004 Dec; 23(24):4857-67. PubMed ID: 15538383
[TBL] [Abstract][Full Text] [Related]
55. Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.
Tee AE; Ciampa OC; Wong M; Fletcher JI; Kamili A; Chen J; Ho N; Sun Y; Carter DR; Cheung BB; Marshall GM; Liu PY; Liu T
Int J Cancer; 2020 Oct; 147(7):1928-1938. PubMed ID: 32086952
[TBL] [Abstract][Full Text] [Related]
56. Feedback repression of ornithine decarboxylase synthesis mediated by antizyme.
Mitchell JL; Choe CY; Judd GG
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):755-60. PubMed ID: 9003359
[TBL] [Abstract][Full Text] [Related]
57. The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.
Lampis S; Raieli S; Montemurro L; Bartolucci D; Amadesi C; Bortolotti S; Angelucci S; Scardovi AL; Nieddu G; Cerisoli L; Paganelli F; Valente S; Fischer M; Martelli AM; Pasquinelli G; Pession A; Hrelia P; Tonelli R
J Exp Clin Cancer Res; 2022 Apr; 41(1):160. PubMed ID: 35490242
[TBL] [Abstract][Full Text] [Related]
58. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
Keren-Paz A; Bercovich Z; Kahana C
Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
[TBL] [Abstract][Full Text] [Related]
59. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma.
Amente S; Milazzo G; Sorrentino MC; Ambrosio S; Di Palo G; Lania L; Perini G; Majello B
Oncotarget; 2015 Jun; 6(16):14572-83. PubMed ID: 26062444
[TBL] [Abstract][Full Text] [Related]
60. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport.
He Y; Suzuki T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 1994 Aug; 203(1):608-14. PubMed ID: 8074711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
